{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:59:53Z","timestamp":1790503193785,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA204002"],"award-info":[{"award-number":["R01CA204002"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA216846"],"award-info":[{"award-number":["R01 CA216846"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["K12CA215110"],"award-info":[{"award-number":["K12CA215110"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005190","name":"Melanoma Research Alliance","doi-asserted-by":"publisher","award":["#308721"],"award-info":[{"award-number":["#308721"]}],"id":[{"id":"10.13039\/100005190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["130157-RSG-16-216-01-TBG"],"award-info":[{"award-number":["130157-RSG-16-216-01-TBG"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["KL2 TR000140"],"award-info":[{"award-number":["KL2 TR000140"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We aimed to study mechanisms controlling metastatic outgrowth of melanoma into clinically relevant lesions, a critical process responsible for the majority of melanoma deaths. To this end, we developed novel in vivo models and identified molecular events that can be ascribed to their distinct phenotypes, indolent or highly metastatic. Induction of a proliferative state at distant sites was associated with high levels of the stem-like\/progenitor marker, SOX2, and required the\u00a0upregulation of FMOD, an extracellular matrix component, which modulates tumor\u2013stroma interactions. Functional studies revealed a possible link between FMOD and SOX2; dual FMOD and SOX2 silencing nearly abolished brain metastasis and had a similar effect on distant metastasis to other sites. Our in vitro data suggests that FMOD and SOX2 cooperation plays an important role in tumor vasculogenic mimicry. Furthermore, we found that FMOD and SOX2 functional roles might converge at the activation of transcriptional co-factors YAP and TAZ, possibly via crosstalk with the tumor suppressor Hippo pathway. Finally, high expression of both genes in patient specimens predicted early development of brain metastasis. Thus, our study identifies FMOD and SOX2 cooperation as a novel regulatory mechanism that might be linked functionally to melanoma metastatic competence.<\/jats:p>","DOI":"10.1007\/s00018-022-04364-5","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T04:02:36Z","timestamp":1655956956000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Coupled fibromodulin and SOX2 signaling as a critical regulator of metastatic outgrowth in melanoma"],"prefix":"10.1007","volume":"79","author":[{"given":"Victor O.","family":"Oria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Zito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetan K.","family":"Rane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-Yong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia K.","family":"Provance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thuy T.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adebowale","family":"Adeniran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuval","family":"Kluger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Sznol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus W.","family":"Bosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harriet M.","family":"Kluger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8900-5083","authenticated-orcid":false,"given":"Lucia B.","family":"Jilaveanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,23]]},"reference":[{"issue":"7586","key":"4364_CR1","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature17038","volume":"529","author":"J Massague","year":"2016","unstructured":"Massague J, Obenauf AC (2016) Metastatic colonization by circulating tumour cells. Nature 529(7586):298\u2013306","journal-title":"Nature"},{"issue":"3","key":"4364_CR2","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.stem.2014.02.002","volume":"14","author":"T Oskarsson","year":"2014","unstructured":"Oskarsson T, Batlle E, Massague J (2014) Metastatic stem cells: sources, niches, and vital pathways. Cell Stem Cell 14(3):306\u2013321","journal-title":"Cell Stem Cell"},{"key":"4364_CR3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3389\/fonc.2020.00397","volume":"10","author":"S Brassart-Pasco","year":"2020","unstructured":"Brassart-Pasco S, Brezillon S, Brassart B, Ramont L, Oudart JB, Monboisse JC (2020) Tumor microenvironment: extracellular matrix alterations influence tumor progression. Front Oncol 10:397","journal-title":"Front Oncol"},{"issue":"7","key":"4364_CR4","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1158\/0008-5472.CAN-19-2961","volume":"80","author":"JD Hebert","year":"2020","unstructured":"Hebert JD, Myers SA, Naba A, Abbruzzese G, Lamar JM, Carr SA et al (2020) Proteomic profiling of the ECM of xenograft breast cancer metastases in different organs reveals distinct metastatic niches. Cancer Res 80(7):1475\u20131485","journal-title":"Cancer Res"},{"key":"4364_CR5","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.3389\/fonc.2019.01482","volume":"9","author":"Z Elgundi","year":"2019","unstructured":"Elgundi Z, Papanicolaou M, Major G, Cox TR, Melrose J, Whitelock JM et al (2019) Cancer metastasis: the role of the extracellular matrix and the heparan sulfate proteoglycan perlecan. Front Oncol 9:1482","journal-title":"Front Oncol"},{"issue":"5","key":"4364_CR6","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/j.1582-4934.2010.01236.x","volume":"15","author":"RV Iozzo","year":"2011","unstructured":"Iozzo RV, Sanderson RD (2011) Proteoglycans in cancer biology, tumour microenvironment and angiogenesis. J Cell Mol Med 15(5):1013\u20131031","journal-title":"J Cell Mol Med"},{"issue":"4","key":"4364_CR7","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1083\/jcb.201102147","volume":"196","author":"P Lu","year":"2012","unstructured":"Lu P, Weaver VM, Werb Z (2012) The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol 196(4):395\u2013406","journal-title":"J Cell Biol"},{"issue":"1","key":"4364_CR8","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nm.2072","volume":"16","author":"Y Kienast","year":"2010","unstructured":"Kienast Y, von Baumgarten L, Fuhrmann M, Klinkert WE, Goldbrunner R, Herms J et al (2010) Real-time imaging reveals the single steps of brain metastasis formation. Nat Med 16(1):116\u2013122","journal-title":"Nat Med"},{"issue":"11","key":"4364_CR9","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1016\/j.celrep.2015.11.025","volume":"13","author":"MY Del Pozo","year":"2015","unstructured":"Del Pozo MY, Park D, Ramachandran A, Ombrato L, Calvo F, Chakravarty P et al (2015) Mesenchymal cancer cell-stroma crosstalk promotes niche activation, epithelial reversion, and metastatic colonization. Cell Rep 13(11):2456\u20132469","journal-title":"Cell Rep"},{"issue":"7","key":"4364_CR10","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/ncb2767","volume":"15","author":"CM Ghajar","year":"2013","unstructured":"Ghajar CM, Peinado H, Mori H, Matei IR, Evason KJ, Brazier H et al (2013) The perivascular niche regulates breast tumour dormancy. Nat Cell Biol 15(7):807\u2013817","journal-title":"Nat Cell Biol"},{"issue":"11","key":"4364_CR11","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1093\/neuonc\/nox077","volume":"19","author":"DN Cagney","year":"2017","unstructured":"Cagney DN, Martin AM, Catalano PJ, Redig AJ, Lin NU, Lee EQ et al (2017) Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study. Neuro Oncol 19(11):1511\u20131521","journal-title":"Neuro Oncol"},{"issue":"5","key":"4364_CR12","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/cncr.32611","volume":"126","author":"H Zhang","year":"2020","unstructured":"Zhang H, Zhu H, Deng G, Zito CR, Oria VO, Rane CK et al (2020) PLEKHA5 regulates tumor growth in metastatic melanoma. Cancer 126(5):1016\u20131030","journal-title":"Cancer"},{"issue":"8","key":"4364_CR13","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1096\/fj.08-126920","volume":"23","author":"I Serganova","year":"2009","unstructured":"Serganova I, Moroz E, Vider J, Gogiberidze G, Moroz M, Pillarsetty N et al (2009) Multimodality imaging of TGFbeta signaling in breast cancer metastases. FASEB J 23(8):2662\u20132672","journal-title":"FASEB J"},{"issue":"9","key":"4364_CR14","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1158\/1078-0432.CCR-14-0861","volume":"21","author":"LB Jilaveanu","year":"2015","unstructured":"Jilaveanu LB, Parisi F, Barr ML, Zito CR, Cruz-Munoz W, Kerbel RS et al (2015) PLEKHA5 as a biomarker and potential mediator of melanoma brain metastasis. Clin Cancer Res 21(9):2138\u20132147","journal-title":"Clin Cancer Res"},{"issue":"7249","key":"4364_CR15","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/nature08021","volume":"459","author":"PD Bos","year":"2009","unstructured":"Bos PD, Zhang XH, Nadal C, Shu W, Gomis RR, Nguyen DX et al (2009) Genes that mediate breast cancer metastasis to the brain. Nature 459(7249):1005\u20131009","journal-title":"Nature"},{"issue":"2","key":"4364_CR16","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/0006-8993(93)91064-Y","volume":"625","author":"AA Hurwitz","year":"1993","unstructured":"Hurwitz AA, Berman JW, Rashbaum WK, Lyman WD (1993) Human fetal astrocytes induce the expression of blood-brain barrier specific proteins by autologous endothelial cells. Brain Res 625(2):238\u2013243","journal-title":"Brain Res"},{"issue":"1","key":"4364_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11060-020-03619-0","volume":"152","author":"SA Weiss","year":"2021","unstructured":"Weiss SA, Zito C, Tran T, Heishima K, Neumeister V, McGuire J et al (2021) Melanoma brain metastases have lower T cell content and microvessel density compared to matched extracranial metastases. J Neurooncol 152(1):15\u201325","journal-title":"J Neurooncol"},{"issue":"1","key":"4364_CR18","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s40425-019-0684-z","volume":"7","author":"TT Tran","year":"2019","unstructured":"Tran TT, Mahajan A, Chiang VL, Goldberg SB, Nguyen DX, Jilaveanu LB et al (2019) Perilesional edema in brain metastases: potential causes and implications for treatment with immune therapy. J Immunother Cancer 7(1):200","journal-title":"J Immunother Cancer"},{"key":"4364_CR19","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.omto.2020.03.001","volume":"17","author":"W Xiao","year":"2020","unstructured":"Xiao W, Zheng S, Xie X, Li X, Zhang L, Yang A et al (2020) SOX2 promotes brain metastasis of breast cancer by upregulating the expression of FSCN1 and HBEGF. Mol Ther Oncolytics 17:118\u2013129","journal-title":"Mol Ther Oncolytics"},{"issue":"8","key":"4364_CR20","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/s41571-019-0181-9","volume":"16","author":"EA Kuczynski","year":"2019","unstructured":"Kuczynski EA, Vermeulen PB, Pezzella F, Kerbel RS, Reynolds AR (2019) Vessel co-option in cancer. Nat Rev Clin Oncol 16(8):469\u2013493","journal-title":"Nat Rev Clin Oncol"},{"key":"4364_CR21","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.biopha.2016.12.110","volume":"87","author":"Z Ao","year":"2017","unstructured":"Ao Z, Yu S, Qian P, Gao W, Guo R, Dong X et al (2017) Tumor angiogenesis of SCLC inhibited by decreased expression of FMOD via downregulating angiogenic factors of endothelial cells. Biomed Pharmacother 87:539\u2013547","journal-title":"Biomed Pharmacother"},{"key":"4364_CR22","doi-asserted-by":"publisher","first-page":"6137","DOI":"10.12659\/MSM.911669","volume":"24","author":"M Chen","year":"2018","unstructured":"Chen M, Ba H, Lu C, Dai J, Sun J (2018) Glial cell line-derived neurotrophic factor (GDNF) promotes angiogenesis through the demethylation of the fibromodulin (FMOD) promoter in glioblastoma. Med Sci Monit 24:6137\u20136143","journal-title":"Med Sci Monit"},{"issue":"1","key":"4364_CR23","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1172\/JCI69404","volume":"124","author":"I Adini","year":"2014","unstructured":"Adini I, Ghosh K, Adini A, Chi ZL, Yoshimura T, Benny O et al (2014) Melanocyte-secreted fibromodulin promotes an angiogenic microenvironment. J Clin Invest 124(1):425\u2013436","journal-title":"J Clin Invest"},{"issue":"8","key":"4364_CR24","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1038\/s41388-021-02157-x","volume":"41","author":"L de Wet","year":"2022","unstructured":"de Wet L, Williams A, Gillard M, Kregel S, Lamperis S, Gutgesell LC et al (2022) SOX2 mediates metabolic reprogramming of prostate cancer cells. Oncogene 41(8):1190\u20131202","journal-title":"Oncogene"},{"issue":"27","key":"4364_CR25","doi-asserted-by":"publisher","first-page":"44917","DOI":"10.18632\/oncotarget.16570","volume":"8","author":"EL Wuebben","year":"2017","unstructured":"Wuebben EL, Rizzino A (2017) The dark side of SOX2: cancer\u2014a comprehensive overview. Oncotarget 8(27):44917\u201344943","journal-title":"Oncotarget"},{"issue":"33","key":"4364_CR26","doi-asserted-by":"publisher","first-page":"4626","DOI":"10.1038\/s41388-018-0292-2","volume":"37","author":"G Maurizi","year":"2018","unstructured":"Maurizi G, Verma N, Gadi A, Mansukhani A, Basilico C (2018) Sox2 is required for tumor development and cancer cell proliferation in osteosarcoma. Oncogene 37(33):4626\u20134632","journal-title":"Oncogene"},{"issue":"5","key":"4364_CR27","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3390\/cells8050407","volume":"8","author":"T Azad","year":"2019","unstructured":"Azad T, Ghahremani M, Yang X (2019) The role of YAP and TAZ in angiogenesis and vascular mimicry. Cells 8(5):407","journal-title":"Cells"},{"key":"4364_CR28","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.3389\/fonc.2019.01419","volume":"9","author":"ON Hernandez de la Cruz","year":"2019","unstructured":"Hernandez de la Cruz ON, Lopez-Gonzalez JS, Garcia-Vazquez R, Salinas-Vera YM, Muniz-Lino MA, Aguilar-Cazares D et al (2019) Regulation networks driving vasculogenic mimicry in solid tumors. Front Oncol 9:1419","journal-title":"Front Oncol"},{"key":"4364_CR29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1756-9966-32-75","volume":"32","author":"Y Qu","year":"2013","unstructured":"Qu Y, Zhang L, Rong Z, He T, Zhang S (2013) Number of glioma polyploid giant cancer cells (PGCCs) associated with vasculogenic mimicry formation and tumor grade in human glioma. J Exp Clin Cancer Res 32:75","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"4364_CR30","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S0002-9440(10)65173-5","volume":"155","author":"AJ Maniotis","year":"1999","unstructured":"Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe\u2019er J et al (1999) Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 155(3):739\u2013752","journal-title":"Am J Pathol"},{"issue":"2","key":"4364_CR31","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3390\/cancers10020045","volume":"10","author":"S Chakraborty","year":"2018","unstructured":"Chakraborty S, Hong W (2018) Linking extracellular matrix agrin to the hippo pathway in liver cancer and beyond. Cancers (Basel) 10(2):45","journal-title":"Cancers (Basel)"},{"issue":"4","key":"4364_CR32","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3390\/cancers10040115","volume":"10","author":"JSA Warren","year":"2018","unstructured":"Warren JSA, Xiao Y, Lamar JM (2018) YAP\/TAZ activation as a target for treating metastatic cancer. Cancers (Basel) 10(4):115","journal-title":"Cancers (Basel)"},{"issue":"9","key":"4364_CR33","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1111\/jcmm.12851","volume":"20","author":"Q Liu","year":"2016","unstructured":"Liu Q, Qiao L, Liang N, Xie J, Zhang J, Deng G et al (2016) The relationship between vasculogenic mimicry and epithelial-mesenchymal transitions. J Cell Mol Med 20(9):1761\u20131769","journal-title":"J Cell Mol Med"},{"issue":"5","key":"4364_CR34","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/ijc.27324","volume":"131","author":"S Izraely","year":"2012","unstructured":"Izraely S, Sagi-Assif O, Klein A, Meshel T, Tsarfaty G, Pasmanik-Chor M et al (2012) The metastatic microenvironment: brain-residing melanoma metastasis and dormant micrometastasis. Int J Cancer 131(5):1071\u20131082","journal-title":"Int J Cancer"},{"key":"4364_CR35","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12935-019-0870-6","volume":"19","author":"MH Pourhanifeh","year":"2019","unstructured":"Pourhanifeh MH, Mohammadi R, Noruzi S, Hosseini SA, Fanoudi S, Mohamadi Y et al (2019) The role of fibromodulin in cancer pathogenesis: implications for diagnosis and therapy. Cancer Cell Int 19:157","journal-title":"Cancer Cell Int"},{"issue":"10","key":"4364_CR36","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/nm1630","volume":"13","author":"Y Bi","year":"2007","unstructured":"Bi Y, Ehirchiou D, Kilts TM, Inkson CA, Embree MC, Sonoyama W et al (2007) Identification of tendon stem\/progenitor cells and the role of the extracellular matrix in their niche. Nat Med 13(10):1219\u20131227","journal-title":"Nat Med"},{"issue":"14","key":"4364_CR37","doi-asserted-by":"publisher","first-page":"9636","DOI":"10.1074\/jbc.274.14.9636","volume":"274","author":"L Svensson","year":"1999","unstructured":"Svensson L, Aszodi A, Reinholt FP, Fassler R, Heinegard D, Oldberg A (1999) Fibromodulin-null mice have abnormal collagen fibrils, tissue organization, and altered lumican deposition in tendon. J Biol Chem 274(14):9636\u20139647","journal-title":"J Biol Chem"},{"key":"4364_CR38","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.biocel.2016.09.023","volume":"80","author":"AT Jan","year":"2016","unstructured":"Jan AT, Lee EJ, Choi I (2016) Fibromodulin: a regulatory molecule maintaining cellular architecture for normal cellular function. Int J Biochem Cell Biol 80:66\u201370","journal-title":"Int J Biochem Cell Biol"},{"issue":"3","key":"4364_CR39","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.bbrc.2013.06.005","volume":"436","author":"J Jian","year":"2013","unstructured":"Jian J, Zheng Z, Zhang K, Rackohn TM, Hsu C, Levin A et al (2013) Fibromodulin promoted in vitro and in vivo angiogenesis. Biochem Biophys Res Commun 436(3):530\u2013535","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"4364_CR40","doi-asserted-by":"publisher","DOI":"10.1097\/GOX.0000000000000243","volume":"2","author":"Z Zheng","year":"2014","unstructured":"Zheng Z, Jian J, Velasco O, Hsu CY, Zhang K, Levin A et al (2014) Fibromodulin enhances angiogenesis during cutaneous wound healing. Plast Reconstr Surg Glob Open 2(12):e275","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"1","key":"4364_CR41","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/onc.2016.176","volume":"36","author":"B Mondal","year":"2017","unstructured":"Mondal B, Patil V, Shwetha SD, Sravani K, Hegde AS, Arivazhagan A et al (2017) Integrative functional genomic analysis identifies epigenetically regulated fibromodulin as an essential gene for glioma cell migration. Oncogene 36(1):71\u201383","journal-title":"Oncogene"},{"issue":"35","key":"4364_CR42","doi-asserted-by":"publisher","first-page":"13966","DOI":"10.1073\/pnas.0702014104","volume":"104","author":"A Oldberg","year":"2007","unstructured":"Oldberg A, Kalamajski S, Salnikov AV, Stuhr L, Morgelin M, Reed RK et al (2007) Collagen-binding proteoglycan fibromodulin can determine stroma matrix structure and fluid balance in experimental carcinoma. Proc Natl Acad Sci U S A 104(35):13966\u201313971","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"15","key":"4364_CR43","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.1158\/0008-5472.CAN-16-0485","volume":"76","author":"H Schwartz","year":"2016","unstructured":"Schwartz H, Blacher E, Amer M, Livneh N, Abramovitz L, Klein A et al (2016) Incipient melanoma brain metastases instigate astrogliosis and neuroinflammation. Cancer Res 76(15):4359\u20134371","journal-title":"Cancer Res"},{"issue":"2","key":"4364_CR44","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41388-019-0997-x","volume":"39","author":"T Schaefer","year":"2020","unstructured":"Schaefer T, Lengerke C (2020) SOX2 protein biochemistry in stemness, reprogramming, and cancer: the PI3K\/AKT\/SOX2 axis and beyond. Oncogene 39(2):278\u2013292","journal-title":"Oncogene"},{"issue":"2","key":"4364_CR45","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/jmcb\/mjy080","volume":"12","author":"MA Mamun","year":"2020","unstructured":"Mamun MA, Mannoor K, Cao J, Qadri F, Song X (2020) SOX2 in cancer stemness: tumor malignancy and therapeutic potentials. J Mol Cell Biol 12(2):85\u201398","journal-title":"J Mol Cell Biol"},{"issue":"1","key":"4364_CR46","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.cell.2016.02.025","volume":"165","author":"S Malladi","year":"2016","unstructured":"Malladi S, Macalinao DG, Jin X, He L, Basnet H, Zou Y et al (2016) Metastatic latency and immune evasion through autocrine inhibition of WNT. Cell 165(1):45\u201360","journal-title":"Cell"},{"key":"4364_CR47","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.biomaterials.2016.01.013","volume":"83","author":"CS Li","year":"2016","unstructured":"Li CS, Yang P, Ting K, Aghaloo T, Lee S, Zhang Y et al (2016) Fibromodulin reprogrammed cells: A novel cell source for bone regeneration. Biomaterials 83:194\u2013206","journal-title":"Biomaterials"},{"issue":"24","key":"4364_CR48","doi-asserted-by":"publisher","first-page":"5821","DOI":"10.1016\/j.biomaterials.2012.04.049","volume":"33","author":"Z Zheng","year":"2012","unstructured":"Zheng Z, Jian J, Zhang X, Zara JN, Yin W, Chiang M et al (2012) Reprogramming of human fibroblasts into multipotent cells with a single ECM proteoglycan, fibromodulin. Biomaterials 33(24):5821\u20135831","journal-title":"Biomaterials"},{"issue":"4","key":"4364_CR49","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.celrep.2019.03.085","volume":"27","author":"E Wingrove","year":"2019","unstructured":"Wingrove E, Liu ZZ, Patel KD, Arnal-Estape A, Cai WL, Melnick MA et al (2019) Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis. Cell Rep 27(4):1277\u201392.e7","journal-title":"Cell Rep"},{"issue":"1","key":"4364_CR50","doi-asserted-by":"publisher","first-page":"82","DOI":"10.18632\/oncoscience.11","volume":"1","author":"V Nygaard","year":"2014","unstructured":"Nygaard V, Prasmickaite L, Vasiliauskaite K, Clancy T, Hovig E (2014) Melanoma brain colonization involves the emergence of a brain-adaptive phenotype. Oncoscience 1(1):82\u201394","journal-title":"Oncoscience"},{"key":"4364_CR51","volume-title":"Introduction to cancer metastasis","author":"DH Murrell","year":"2017","unstructured":"Murrell DH (2017) Introduction to cancer metastasis. Academic Press"},{"issue":"6","key":"4364_CR52","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1002\/stem.1993","volume":"33","author":"N Bora-Singhal","year":"2015","unstructured":"Bora-Singhal N, Nguyen J, Schaal C, Perumal D, Singh S, Coppola D et al (2015) YAP1 regulates OCT4 activity and SOX2 expression to facilitate self-renewal and vascular mimicry of stem-like cells. Stem Cells 33(6):1705\u20131718","journal-title":"Stem Cells"},{"issue":"3","key":"4364_CR53","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.celrep.2019.12.075","volume":"30","author":"H Ma","year":"2020","unstructured":"Ma H, Wang J, Zhao X, Wu T, Huang Z, Chen D et al (2020) Periostin promotes colorectal tumorigenesis through integrin-FAK-Src pathway-mediated YAP\/TAZ activation. Cell Rep 30(3):793-806.e6","journal-title":"Cell Rep"},{"issue":"11","key":"4364_CR54","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1038\/s41416-019-0608-1","volume":"121","author":"S He","year":"2019","unstructured":"He S, Huang Q, Hu J, Li L, Xiao Y, Yu H et al (2019) EWS-FLI1-mediated tenascin-C expression promotes tumour progression by targeting MALAT1 through integrin alpha5beta1-mediated YAP activation in Ewing sarcoma. Br J Cancer 121(11):922\u2013933","journal-title":"Br J Cancer"},{"key":"4364_CR55","doi-asserted-by":"publisher","first-page":"6411","DOI":"10.1038\/ncomms7411","volume":"6","author":"U Basu-Roy","year":"2015","unstructured":"Basu-Roy U, Bayin NS, Rattanakorn K, Han E, Placantonakis DG, Mansukhani A et al (2015) Sox2 antagonizes the Hippo pathway to maintain stemness in cancer cells. Nat Commun 6:6411","journal-title":"Nat Commun"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-022-04364-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-022-04364-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-022-04364-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T17:19:52Z","timestamp":1666372792000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-022-04364-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,23]]},"references-count":55,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["4364"],"URL":"https:\/\/doi.org\/10.1007\/s00018-022-04364-5","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,23]]},"assertion":[{"value":"9 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"HMK reports grants (outside of the submitted work) from Merck, Bristol-Myers Squibb and Apexigen and personal fees from Nektar, Iovance, Celldex, Array Biopharma, Merck, Elevate Bio, Instil Bio, Bristol-Myers Squibb, Clinigen, Shionogi, Chemocentryx, Calithera, and Signatero. MS reports stock or stock options at: Adaptive Biotechnologies\u2014stock options, Amphivena\u2014stock options, Intensity\u2014stock options, Actym\u2014stock options, Johnson and Johnson\u2014stock, Glaxo-Smith Kline\u2014stock, Evolveimmune\u2014stock options, Nextcure\u2014stock options, Repertoire\u2014stock options, Oncohost\u2014stock options. MS also reports consulting fees from Kanaph, Adagene, Asher, Targovax, Ontario Institute for Cancer Research, Gilead, Sapience, iTEOS, Incyte, Pfizer, Jazz Pharmaceuticals, Tessa, Oncosec, Biontech, Trillium, Stcube, Regeneron, Simcha, Numab, Incyte, Astra Zeneca, Molecular Partners, Idera, Apexigen, Evolveimmune, Alligator, Verastem, Agenus, Rubius, Bristol-Myers, Genentech-Roche, Boston Pharmaceuticals, Nextcure, Servier, Adaptimmune, Immunocore, Dragonfly, Pierre-Fabre, Boehringer Ingelheim, Innate pharma, Nektar, Pieris, Abbvie, Zelluna, Seattle Genetics, Genocea, GI Innovation, Chugai-Roche, Lilly, Modulate Therapeutics, Genmab, and Biond. All the remaining authors have no potential conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All authors consent to the publication of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"377"}}